Calliditas Therapeutics: Q2 Earnings Insights

Calliditas Therapeutics CALT reported its Q2 earnings results on Thursday, August 18, 2022 at 01:00 AM.

Here's what investors need to know about the announcement.

Earnings

Calliditas Therapeutics beat estimated earnings by 26.3%, reporting an EPS of $-0.737 versus an estimate of $-1.0.

Revenue was up $6.51 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.17 which was followed by a 15.45% increase in the share price the next day.

To track all earnings releases for Calliditas Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.